---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-079246"
form_type: "8-K"
ticker: "INM"
cik: "0001728328"
company_name: "InMed Pharmaceuticals Inc."
filed_at: "2022-12-13T23:59:59+00:00"
generated_at: "2026-06-21T05:32:51.169134+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# InMed Pharmaceuticals' auditor KPMG resigns; Marcum appointed as successor

## Summary
- KPMG resigned as independent auditor on Dec 8, 2022, declining to stand for reelection; no disagreements on accounting matters.
- KPMG's FY2022 and FY2021 audit reports included a going-concern paragraph citing substantial doubt about InMed's ability to continue.
- InMed had an unremediated material weakness in internal control over financial reporting as of June 30, 2022.
- Audit Committee appointed Marcum LLP as new auditor on Dec 11, 2022, subject to standard client acceptance procedures.
- No consultations with Marcum before engagement on accounting or audit matters.

## SEC filing metadata
- accession: 0001213900-22-079246
- form_type: 8-K
- ticker: INM
- cik: 0001728328
- company_name: InMed Pharmaceuticals Inc.
- filed_at: 2022-12-13T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728328/000121390022079246/0001213900-22-079246-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728328/000121390022079246/ea170063-8k_inmedpharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-079246
- JSON: https://secwatch.observer/filing/0001213900-22-079246.json
- Plain text: https://secwatch.observer/filing/0001213900-22-079246.txt

## Key facts
- Auditor Changes
  InMed Pharmaceuticals Inc. engaged Marcum LLP as its auditor.
  - Action: engagement
  - Auditor: Marcum LLP
  source text: On December 11, 2022, the Audit Committee approved the engagement of Marcum LLP ("Marcum") to audit our consolidated financial statements for the fiscal year ending June 30, 2023, subject to Marcum's standard client acceptance procedures.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1728328/000121390022079246/0001213900-22-079246-index.htm
- Auditor Changes
  KPMG LLP resigned as auditor of InMed Pharmaceuticals Inc..
  - Action: resignation
  - Auditor: KPMG LLP
  source text: On December 8, 2022, KPMG LLP ("KPMG"), which had been serving as the independent registered public accounting firm of InMed Pharmaceuticals Inc. ("we," "us" or "our"), declined to stand for reelection and resigned as our independent registered public accounting firm, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1728328/000121390022079246/0001213900-22-079246-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.